Business
Remuneration of Non-Executive Directors and TVR's
Remuneration of Non-Executive Directors and TVR's.
About this update from Futura Medical Plc
[{"type":"text","content":"\n\n13 January 2025\nFutura Medical plc\n(\"Futura\" or the \"Company\")\nRemuneration of Non-Executive Directors and Total Voting Rights\n \n \nFutura Medical plc (AIM: FUM) (the \"Company\"), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, announces the issue of 126,116 new ordinary shares of 0.2 pence each (\"Ordinary Shares\") in respect of the 2024 remuneration of its Non-Executive Directors .\n \nRemuneration of Non-Executive Directors\n \nIn accordance with the terms of their service agreements, the Non-Executive Directors receive 25 per cent. of their remuneration in the form of Ordinary Shares. For 2024, these were issued at 27.10 pence per share, being the average closing mid-market price of the last 10 trading days of 2023 (as announced via RNS on 17 January 2024).\n \nThe 126,116 new Ordinary Shares shall rank pari passu with the existing issued Ordinary Shares of the Company and have been issued as follows:\n \n\n\n\n\nDirector\n\n\nNumber of Ordinary Shares issued for 2024 remuneration\n\n\nTotal number of ordinary shares held\n\n\nPercentage of the Company's resulting issued share capital\n\n\n\n\nJeff Needham\n\n\n55,600\n\n\n83,561\n\n\n0.01%\n\n\n\n\nAndrew Unitt\n\n\n30,221\n\n\n68,717\n\n\n0.01%\n\n\n\n\nRoy Davis\n\n\n40,295\n\n\n40,295\n\n\n0.01%\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nThe shares element of the Non-Executive Directors' remuneration for 2025 will be awarded at 32.17 pence per Ordinary Share, being the average closing mid-market price of the last 10 trading days of 2024. The Non-Executive Directors will receive these shares in January 2026.\n \nTotal Voting Rights\n \nApplication has been made to the London Stock Exchange and it is anticipated that trading of the new Ordinary Shares will commence on AIM at 8:00am on 16 January 2025.\n \nImmediately following the above issue, the Company will have 303,829,684 ordinary shares in issue, each carrying one voting right. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company is therefore 303,829,684 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in,...